Physician

Rehan Z Ali, M.D.

According to 2025 Medicare claims, Rehan Ali, M.D. (NPI: 1912198532) practices cardiology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is CARDIOLOGY SPECIALISTS OF ACADIANA, LLC (NPI: 1881863553; TIN: 26-1856390) and primary practice location at 70508-5734. Ali is affiliated with the Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,318 traditional Medicare patients, billed 5,818 HCPCS/CPT codes, and received $473,103 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 6,929 prescription claims across 773 beneficiaries totaling $809,832 in drug costs, led by Xarelto (Rivaroxaban). 2019 DME data shows 16 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $63,573 to $809,832. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,532	4,451	$374,870
2016	2,763	7,534	$531,382
2017	2,342	6,702	$489,790
2018	1,261	5,052	$473,134
2019	1,328	5,047	$470,017
2020	1,738	5,618	$497,899
2021	1,305	5,204	$514,955
2022	1,221	4,879	$416,406
2023	981	5,159	$424,509
2024	1,318	5,818	$473,103

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	1,439	$63,573
2016	264	2,428	$117,888
2017	283	2,773	$175,256
2018	320	3,497	$230,661
2019	378	3,603	$289,068
2020	432	4,270	$381,955
2021	558	5,394	$521,264
2022	623	5,687	$639,970
2023	676	5,777	$733,179
2024	773	6,929	$809,832

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	16	$33,385
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	283	319	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	711	1,216	$76
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	642	659	$74
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	132	132	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	763	1,052	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	547	23,508	$427,630
Eliquis	Apixaban	265	11,046	$211,455
Entresto	Sacubitril/Valsartan	35	1,862	$35,603
Repatha Sureclick	Evolocumab	29	1,764	$33,043
Praluent Pen	Alirocumab	29	812	$14,208

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rehan Z. Ali, M.D.?

Tedicare shows public-source Medicare data for Rehan Z. Ali, M.D. (NPI 1912198532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rehan Z. Ali, M.D. have ACO affiliation data?

Rehan Z. Ali, M.D. is shown with ACO affiliation data for Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Rehan Z. Ali, M.D.?

Rehan Z. Ali, M.D. is linked to CARDIOLOGY SPECIALISTS OF ACADIANA, LLC (billing NPI 1881863553) in the available physician profile data.

Does Rehan Z. Ali, M.D. have Open Payments data?

Rehan Z. Ali, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.